Safe Flu Research Strategy

Researchers develop a new “molecular biocontainment” strategy for safely studying deadly flu viruses.

By | August 12, 2013


Following a year-long, worldwide moratorium on H5N1 research stemming from fears of a global pandemic after researchers showed that the avian flu virus could be spread among ferrets, scientists have released a new “molecular biocontainment” strategy for the safe study of deadly viruses. The protocol, detailed in a paper published Sunday (August 11) in Nature Biotechnology, involves introducing viruses to be studied to human lung cells, which inactivate the viruses.  

“The question last year was whether the risk of altered bird flu escaping laboratories justified the science aimed at understanding the transmission of these viruses,” said Benjamin tenOever, a microbiologist at Mount Sinai, in a statement. “With our method, the possibility of human transmission is no longer a concern.”

The biocontainment method involves altering a virus’s genome to add a binding site for a specific human miRNA found in lung cells, miR-192, which can latch onto and destroy the virus. In this way, the researcher suggest, the virus will be rendered inactive should it escape from the research laboratory. Because miR-192 is not found in ferret lung cells, airborne transmission of viruses can still be studied in ferrets, which are one of the best model systems for studying viral transmission.

The researchers claim that their approach can be used for all type A influenza viruses, including H5N1, an avian virus that has killed 360 people since 2003. The experimental protocol could also be used to study RNA viruses, such as Ebola and SARS. “It is clear that we can apply this technology to any virus,” said tenOever.


Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
LI-COR Biosciences
LI-COR Biosciences

Popular Now

  1. Inside a Lab Mouse’s High-Fat Diet
  2. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

  3. How Gastric Bypass Can Kill Sugar Cravings
  4. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

Life Technologies